The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis
Open accessAbstract
BACKGROUND: Higher circulating levels of the branched-chain amino acids (BCAAs; i.e., isoleucine, leucine, and valine) are strongly associated with higher type 2 diabetes risk, but it is not known whether this association is causal. We undertook large-scale human genetic analyses to address this question. METHODS AND FINDINGS: Genome-wide studies of BCAA levels in 16,596 individuals revealed five genomic regions associated at genome-wide levels of significance (p < 5 × 10-8). The strongest signal was 21 kb upstream of the PPM1K gene (beta in standard deviations [SDs] of leucine per allele = 0.08, p = 3.9 × 10-25), encoding an activator of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-limiting step in BCAA catabolism. In another analysis, in up to 47,877 cases of type 2 diabetes and 267,694 controls, a genetically predicted difference of 1 SD in amino acid level was associated with an odds ratio for type 2 diabetes of 1.44 (95% CI 1.26-1.65, p = 9.5 × 10-8) for isoleucine, 1.85 (95% CI 1.41-2.42, p = 7.3 × 10-6) for leucine, and 1.54 (95% CI 1.28-1.84, p = 4.2 × 10-6) for valine. Estimates were highly consistent with those from prospective observational studies of the association between BCAA levels and incident type 2 diabetes in a meta-analysis of 1,992 cases and 4,319 non-cases. Metabolome-wide association analyses of BCAA-raising alleles revealed high specificity to the BCAA pathway and an accumulation of metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activity. Limitations of this study are that, while the association of genetic variants appeared highly specific, the possibility of pleiotropic associations cannot be entirely excluded. Similar to other complex phenotypes, genetic scores used in the study captured a limited proportion of the heritability in BCAA levels. Therefore, it is possible that only some of the mechanisms that increase BCAA levels or affect BCAA metabolism are implicated in type 2 diabetes. CONCLUSIONS: Evidence from this large-scale human genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, increased SCFA consumption may alleviate the hyperglycemic responses that are occurring in obese and type 2 diabetics, characterized by elevated amino-acid concentrations [154].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [154]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Self-citationDavey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Self-citationAn atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255
Self-citationGut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Cited by
Items 301–400 of 423
Xu, G., An, Y., Du, Y., Cao, Z., Zheng, J., Wang, J., Li, T., Lei, X. G., & Lu, Y. (2025) · iMetaOmics. · doi:10.1002/imo2.70020 · Cited by 7
“Studies have shown that elevated BCAAs levels or alterations in their metabolic profiles are closely linked to T2DM and can significantly predict its onset [78 – 80].”
Mi, M., Whitlock, M., Shi, X. D., Farrell, L. A., Bhambhani, V. M., Quadir, J., Blatnik, M., Wald, K., Tierney, B., Kim, A., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.01.001 · Cited by 6
Harville, E. W., Bazzano, L., Qi, L., He, J., DORANS, K. S., Perng, W., & Kelly, T. N. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.015 · Cited by 11
Branched-chain amino acids and risk of stroke: A Mendelian randomization study
Zhang, Y., Duan, Y., Jiang, M., He, X., Xu, S., Guo, J., Li, M., Zhou, C. Y., Wu, D., Liu, G., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1143718 · Cited by 6
“The genetic variants associated with plasma BCAA levels were obtained for exposure data from a meta-analysis of GWAS of 16,596 European ancestors (Lotta et al., 2016).”
MethodAssociation between type 2 diabetes and branched chain amino acids (BCAA); a case-control study
Torki, S. A., Bahadori, E., Aghakhaninejad, Z., Mohseni, G. K., Tajadod, S., Harsini, A. R., Azaryan, F., Saeedirad, Z., Askarpour, S. A., Mahmoudi, Z., et al. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01247-9 · Cited by 8
Hughes, D. A., Li‐Gao, R., Bull, C. J., de Mutsert, R., Rosendaal, F. R., Mook-Kanamori, D. O., van Dijk, K. W., & Timpson, N. J. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.03.009 · Cited by 7
“…acids and BMI, visceral adipose tissue and weight change [15,56 – 59], between BCAAs and AAAs with insulin resistance and type 2 diabetes [60 – 63], used MR to show that insulin resistance increase BCAAs concentration [64] and used a randomized control trail to show that restricting BCAAs can…”
Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling
Klén, R., Honka, M., Hannukainen, J. C., Huovinen, V., Bucci, M., Latva‐Rasku, A., Venäläinen, M. S., Kalliokoski, K. K., Virtanen, K. A., Läutamaki, R., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa026 · Cited by 6
“Recent Mendelian randomization studies suggest that increased BCAAs may contribute to etiology of T2DM [57] and that insulin resistance increases BCAA concentrations [58, 59].”
BackgroundMaarse, B. C. E., Loh, N. Y., Karpe, F., Rosendaal, F. R., van Heemst, D., Mook‐Kanamori, D. O., van Dijk, K. W., Rensen, P. C. N., Kooijman, S., Christodoulides, C., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.07.030 · Cited by 6
Duan, W., Zi, T., Zhao, Y., Shan, R., Wu, H., Sun, H., Tian, Z., Wang, J., Liu, L., Zhang, Y., et al. (2021) · Aging · doi:10.18632/aging.202777 · Cited by 8
“Importantly, evidence from Mendelian randomization analysis supports the association between BCAA-raising polymorphisms and a higher risk of T2DM, which could interpret the causal role of BCAA metabolism in T2DM risk [41].”
Kettunen, J., Joensuu, A., Hagnäs, M. P., Mikkola, I., Wennerström, A., Lee, J. H., Terwilliger, J. D., Borodulin, K., Jousilahti, P., Jauhiainen, M., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00260.2018 · Cited by 6
“When a person has an increased risk for cardiovascular diseases (CVD) or type 2 diabetes (T2D), it is recommended that they lose excess weight and exercise more.”
BackgroundInfluentialJiang, X., Zhu, F., Graça, G., Du, X., Ran, J., Ahmadizar, F., Wood, A. C., Zhou, Y. R., Scholtens, D. M., Farzaneh, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae812 · Cited by 8
Gurung, R. L., Zheng, H., Tan, I. J. L., Liu, S., Chan, C., Ang, K., Tan, C., Liu, J., Subramaniam, T., Sum, C. F., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70153 · Cited by 7
“37 Elevated BCAAs are associated with insulin resistance, type 2 diabetes (T2D), and metabolic dysfunction, 38 – 41 and a cross-sectional study suggests a paradoxical decline in BCAA concentrations as kidney dysfunction progresses.”
Genetic analysis of circulating metabolic traits in 619,372 individuals
Tambets, R., Jesse, M., Kronberg, J., van der Graaf, A., Abner, E., Võsa, U., Rahu, I., Taba, N., Kolde, A., Yarish, D., et al. (2026) · Nature · doi:10.1038/s41586-026-10532-5 · Cited by 36
Hashemy, H., Nguyen, A., Khafagy, R. T. M., Roshandel, D., Paterson, A. D., & Dash, S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15542 · Cited by 6
“Based on acute in-vivo physiological studies 8,9 and genetic evidence, 10 increased lipid flux with ectopic lipid deposition in the liver, skeletal muscle and pancreas is postulated to contribute to IR, dyslipidaemia and type 2 diabetes (T2D), with further evidence that reduced HDL may also further…”
BackgroundLiu, R., Yang, Y., Shi, G., & Zhang, L. (2024) · Nutrition · doi:10.1016/j.nut.2024.112410 · Cited by 5
Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches
Wittemans, L. B. L., Lotta, L. A., & Langenberg, C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1009-1 · Cited by 8
Self-citationThe impact of persistent milk consumption in the pathogenesis of type 2 diabetes mellitus
Melnik, B. C. (2019) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v9i10.654 · Cited by 5
Mantha, O. L., Huneau, J., Mathé, V., Hermier, D., Khodorova, N., Mariotti, F., & Fouillet, H. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00061.2020 · Cited by 6
Jiang, H., Zhou, C. Y., Wei, H., Wu, Y., Zhou, Y., Xiao, X., Liu, L., Li, M., Duan, J., Meng, R., et al. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231170037 · Cited by 5
Mao, Y., & Feng, J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05188-6 · Cited by 4
Brain amino acid sensing for organismal amino acid homeostasis
Tsang, A. H. K., Samson, L., & Blouet, C. (2025) · Open Biology · doi:10.1098/rsob.250092 · Cited by 4
“Elevated circulating levels of BCAAs are increasingly recognized as a contributing factor to metabolic diseases such as obesity, insulin resistance and type II diabetes [3,4] and several types of cancer [5,6].”
Suthar, K., & Singh, N. (2025) · Biomedical engineering · doi:10.5772/intechopen.1009591 · Cited by 5
Wang, W., van Dijk, K. W., Wijsman, C. A., Rozing, M. P., Mooijaart, S. P., Beekman, M., Slagboom, P. E., Jukema, J. W., Noordam, R., & van Heemst, D. (2021) · Metabolomics · doi:10.1007/s11306-021-01806-2 · Cited by 4
“However, it has also been demonstrated by Mendelian randomization analysis that higher levels of the branched chain amino acids themselves are causally associated with the risk of type 2 diabetes (Lotta, 2016).”
BackgroundHuang, J., Rong, R., Feei, Z., & Chen, Y. (2024) · Nutrients · doi:10.3390/nu16152567 · Cited by 4
“One possible underlying mechanism may be that elevated levels of circulating branched-chain amino acids (BCAAs) resulting from high dietary protein intake are implicated in the etiology of T2D through impaired BCAA metabolism [46].”
BackgroundThe metabolic signature of blood lipids: a causal inference study using twins
Wang, Y., Liu, S., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Liao, C., Pang, Y., Pang, Z., et al. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100625 · Cited by 4
“Previous studies have shown that leucine can predict future conversion to T2DM (48, 49).”
BackgroundIntegrating genetic and transcriptomic data to identify genes underlying obesity risk loci
Xu, H., Gupta, S., Dinsmore, I. R., Kollu, A., Cawley, A. M., Anwar, M. Y., Chen, H., Petty, L. E., Seshadri, S. S., Graff, M., et al. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01898-z · Cited by 6
The search for predictive metabolic biomarkers for incident T2DM
Pearson, E. R., & Adamski, J. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0045-x · Cited by 4
Liu, Y., Gan, L., Zhao, B., Yu, K. F., Wang, Y., Männistö, S., Weinstein, S. J., Huang, J., & Albanes, D. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00287.2022 · Cited by 5
Schulze, M. B., & Hu, F. B. (2022) · Springer eBooks · doi:10.1007/978-1-4614-6625-3_66-1 · Cited by 6
Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study
Ratter-Rieck, J. M., Shi, M., Suhre, K., Prehn, C. P., Adamski, J., Rathmann, W., Thorand, B., Roden, M., Peters, A., Wang‐Sattler, R., et al. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003865 · Cited by 3
Shi, L. S. (2017) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences)) · Cited by 6
Zheng, J., Luan, J., Sofianopoulou, E., Imamura, F., Stewart, I. D., Day, F. R., Pietzner, M., Wheeler, E., Lotta, L. A., Gundersen, T. E., et al. (2020) · doi:10.2337/figshare.13105559 · Cited by 4
Self-citationEvaluating the role of amino acids in type 2 diabetes risk: a Mendelian randomization studyPreprint
Mo, J. M. Y., He, B., Wong, T. H. T., Liang, Y., Luo, S., Lo, K. K.-H., Louie, J. C. Y., & Yeung, S. L. A. (2023) · medRxiv · doi:10.1101/2023.08.27.23294702 · Cited by 3
Bell, H. E., Jackson, K. G., Crompton, L. A., Givens, D. I., & Lovegrove, J. A. (2025) · Nutrition Research Reviews · doi:10.1017/s0954422425100140 · Cited by 5
Lim, Y. J., & van Dam, R. M. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.10.008 · Cited by 4
“Finally, a meta-analysis of genome-wide association studies showed an association between genetic variation in BCAA metabolism and type 2 diabetes, supporting a causal role of BCAAs in diabetes development [11].”
Li, J., Chen, H., Zhou, Y., Sun, L., Xing, Y., Sun, Y., Yang, Y., & Shi, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1778455 · Cited by 5
“Genome-wide association studies have identi fi ed multiple loci associated with plasma BCAA levels, with the PPM1K gene region showing the strongest association (110).”
InfluentialKatz, D. H., & Gerszten, R. E. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.273516 · Cited by 3
Abar, L., Zuber, V., Otto, G., Tzoulaki, I., & Dehghan, A. (2024) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqae046 · Cited by 3
“We further report a potential causal association between serum BCAA levels and diabetes, as supported by previous observational ( 32 ,33 ) and MR studies ( 2 ,3 ).”
ResultXu, Y., Jiang, H., & Liu, J. (2020) · Circulation · doi:10.1161/circulationaha.120.051367 · Cited by 3
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY studyPreprint
Slieker, R. C., Donnelly, L. A., López–Noriega, L., Muniangi-Muhitu, H., Akalestou, E., Sheikh, M., Georgiadou, E., Giordano, G. N., Åkerlund, M., Ahlqvist, E., et al. (2021) · medRxiv · doi:10.1101/2021.04.22.21255625 · Cited by 5
Compton, H., Smith, M. L., Bull, C. J., Korologou‐Linden, R., Ben‐Shlomo, Y., Bell, J. A., & Anderson, E. L. (2022) · medRxiv · doi:10.1101/2022.03.24.22272867 · Cited by 3
Mildly elevated liver lipid content is characterised by reduced insulin sensitivity
Tuomola, N., Rebelos, E., Latva‐Rasku, A., Bucci, M., Immonen, H., Saunavaara, V., Laine, S., Sjöros, T., Garthwaite, T., Raiko, J. R. H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101535 · Cited by 5
“50 However, the role of BCAAs in the pathogenesis of T2D is controversial based on genetic studies 48,51,52 and a recent study did not find evidence for an effect of BCAAs on MASLD risk or vice versa .”
Zhou, X., Lu, J., Wang, Z., Cheng, K. K., & Li, G. H. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70565 · Cited by 3
“Moreover, these studies largely considered T2D as the only endpoint, 9,10 leaving uncertainty about which specific T2D-related pathogenic events drive these associations.”
Metabolic reprogramming drives pancreatic β cell neogenesis from α cells
Zhang, Y., Lu, G., Xie, W., Xu, P. H., Liu, C., Babošová, O., Reilly, J. C., Li, Z., Chen, L., Zhou, L., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02293-z · Cited by 4
Beuchel, C. F., Dittrich, J., Becker, S., Kirsten, H., Tönjes, A., Kovacs, P. L., Stümvoll, M., Loeffler, M., Teren, A., Thiery, J., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02362-z · Cited by 3
“For this purpose, we created a catalogue of 52 genes reported for association with BMI (Supplemental Table S3) [60, 61].”
BackgroundMethodToki, R., Fushiki, S., Kojima, S., Sutoh, Y., Otsuka‐Yamasaki, Y., Harada, S., Iida, M., Hirata, A., Miyagawa, N., Matsumoto, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-98992-z · Cited by 3
Circulating Amino Acid Changes Three Years After Bariatric Surgery
Maltais‐Payette, I., Lajeunesse‐Trempe, F., Nadeau, M., Bouvet-Bouchard, L., Hould, F. S., Biertho, L. D., & Tchernof, A. (2025) · Metabolites · doi:10.3390/metabo15050297 · Cited by 2
“Mendelian randomization analyses have demonstrated that plasma levels of BCAAs are associated with a small but significant increase in the risk of developing type 2 diabetes [29].”
Metabolomics for Biomarker Discovery and to Derive Genetic Links to Disease
Sumner, S., McRitchie, S., & Pathmasiri, W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-804572-5.00010-0 · Cited by 2
Metabolomic profile of colorectal cancer patients and its clinical implications
Răchieriu, C., Graur, F., Moiș, E. I., Socaciu, C., Eniu, D. T., & Hajjar, N. A. (2020) · ROMANIAN BIOTECHNOLOGICAL LETTERS · doi:10.25083/rbl/25.6/2045.2054 · Cited by 2
“A large scale genetic and metabolomic study is consistent with a causal role of BCAA metabolism in the aetiology of type 2 diabetes [47].”
Sjögren, R. J. O., Rizo‐Roca, D., Chibalin, A., Chorell, E., Furrer, R., Katayama, S., Harada, J., Karlsson, H. K. R., Handschin, C., Moritz, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.24.218099 · Cited by 2
“to impaired BCAA catabolism and higher risk of T2D (Lotta et al., 2016).”
BackgroundSelf-citationAre Branched Chain Amino Acids the Potential Targets for Lifestyle Interventions in Youth?
Qi, L. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab631 · Cited by 2
Liu, Y., Wu, H., Liu, B., Chen, S., Huang, L., Liu, Z., Wang, J., Xie, L., & Wu, X. (2022) · Research Square · doi:10.21203/rs.3.rs-2346866/v1 · Cited by 2
Takase, M., Nakaya, N., Kogure, M., Hatanaka, R., Nakaya, K., Chiba, I., Tokioka, S., Nochioka, K., Nakamura, T., Tsuchiya, N., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02849-8 · Cited by 1
“The association of leucine and valine with the T2DM risk was confirmed in previous studies and Mendelian randomization analysis [40, 41], and this was consistent with our findings.”
Li, K., Zhang, C., & Yan, C. (2025) · The FASEB Journal · doi:10.1096/fj.202501757r · Cited by 1
Wang, Y., Xiao, J.-H., Zhang, X.-M., Wang, W.-X., Zhang, Q., Tang, Y., & Yue, S. (2025) · PeerJ · doi:10.7717/peerj.20054 · Cited by 1
Metabolomics and Genomics in Endocrinology
Bandarian, F., Dehghanbanadaki, H., Khashayar, P., Rezaei–Tavirani, M., Amoli, M. M., Panahi, N., Bandarian, M., & Razi, F. (2025) · Springer eBooks · doi:10.1007/978-981-95-2286-6_7 · Cited by 1
Fang, Y., Cai, Y., Chen, X., & Lin, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1698112 · Cited by 2
Chetana, S., & Kalyani, B. (2025) · Cardiovascular Toxicology · doi:10.1007/s12012-025-10079-3 · Cited by 1
“The PPM1K gene, which is an activator of BCKD, predicted higher BCAA levels, which were associated with type 2 diabetes risk [28 ].”
Li, S.-Y., Zhang, T., Leung, J. C. S., & Kwok, T. C. Y. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106590 · Cited by 1
Muigano, M. N. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2026.1847345 · Cited by 1
Multi‐omics–driven precision medicine
Li, H., Zhao, Z., Zhang, Y., Ma, Y., Hu, G., Zeng, M., Yang, Z., Zhao, Z., Zhou, X., Hu, W., et al. (2026) · iMeta · doi:10.1002/imt2.70165 · Cited by 2
Estimating and testing direct genetic effects in directed acyclic graphs using estimating equations
Konigorski, S., Wang, Y., Çiğşar, C., & Yilmaz, Y. E. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22107 · Cited by 3
“…studies in general, truly show evidence of functional genetic effects (e.g., through genetically determined circulating biomarkers on type 2 diabetes, Lotta et al., 2016, or coronary artery disease, Helgadottir et al., 2016), of pleiotropic genetic effects on multiple phenotypes, or if 174 Genet.”
BackgroundComparison of Analytical Methods Of Serum Untargeted Metabolomics
Fonseca, T. A. H., Oliveira, M. C., Araújo, R., Bento, L. F. N., Rekowski, C. P. V., Justino, G. C., & Calado, C. R. C. (2023) · IEEE Portuguese Meeting on Bioengineering · doi:10.1109/enbeng58165.2023.10175339 · Cited by 1
“as a starting point towards personalized medicine [5], by allowing the discovery of biomarkers for disease diagnosis such as Parkinson's disease [6], type 2 diabetes [7], and transplant rejection [8], among others.”
BackgroundEffect of Growth Hormone on Branched‐Chain Amino Acids Catabolism in Males With Hypopituitarism
Zhang, Y., Ye, Z., Xiang, E., Chen, P., & Fang, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70451 · Cited by 1
Lotta, L. A., Dong, L., Li, C., Patel, S., Stewart, I. D., Lim, K., Day, F. R., Wheeler, E., Glastonbury, C. A., de Streek, M. V., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/372128 · Cited by 2
“Lipid association estimates were not available for rs150090666 in the Global Lipids Genetics Consortium, so they were estimated in the Fenland, InterAct and EPIC-Norfolk studies.”
BackgroundMethodInfluentialSelf-citationThe Identification of Hub Genes and Pathways in type 2 Diabetes Mellitus by Bioinformatics AnalysisPreprint
Li, J., Jiang, X., Chen, L., & Chen, H. (2020) · Research Square · doi:10.21203/rs.3.rs-58811/v1 · Cited by 1
Hall, E. C. R., Semenova, E. A., Bondareva, E. A., Larin, A. K., Generozov, E. V., & Ahmetov, I. I. (2022) · Preprints.org · doi:10.20944/preprints202201.0350.v1
“Previous investigations involved sedentary and/or T2D populations [18], and ours physically active participants.”
BackgroundInfluentialBranched-Chain Keto Acid Inhibits Mitochondrial Pyruvate Carrier and Suppresses GluconeogenesisPreprint
Nishi, K., Abell, L., Frausto, R. F., Ritterhoff, J., McMillen, T. S., Sweet, I. R., Wang, Y., Gao, C., & Tian, R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4022706 · Cited by 1
Zheng, J., Luan, J., Sofianopoulou, E., Imamura, F., Stewart, I. D., Day, F. R., Pietzner, M., Wheeler, E., Lotta, L. A., Gundersen, T. E., et al. (2020) · doi:10.2337/figshare.13105559.v1 · Cited by 1
Self-citationHullar, M. A. J., Curtis, K. R., Li, Y., Lampe, J. W., Jenkins, I., Randolph, T. W., Lim, U., Wilkens, L. R., Marchand, L. L., Kristal, B. S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2298426/v1 · Cited by 2
Insights into the metabolic consequences of type 2 diabetesPreprint
Bocher, O., Singh, A., Huang, Y., Võsa, U., Reimann, E., Arruda, A. L., Barysenka, A., Kolde, A., Rayner, N. W., Esko, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599832 · Cited by 1
Using genetics to inform new therapeutics for diabetes
Yu, A. C.-S., Li, J., & Chan, T. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1323631
“They discovered that BCAAraising genetic variants, which are implicated in BCAA catabolism, and higher level of BCAA are associated with T2D risk [6].”
BackgroundBranched Chain Amino Acids: Causal or Predictive of Type 2 Diabetes
George, J. (2017) · Digital Archive @ GSU · doi:10.57709/10310360
Applications of Metabolic Phenotyping in Epidemiology
Pinto, R. C., Karaman, İ., Fussell, J. C., Εvangelou, Ε., Kelly, F. J., Elliott, P., & Tzoulaki, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812293-8.00017-7
Yazdani, A., Yazdani, A., Elsea, S. H., Schaid, D. J., Kosorok, M. R., Dangol, G., & Samiei, A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1904.12652
“Studies have shown that higher levels of leucine or isoleucine are strongly related to insulin resistance, obesity, and higher risk of type 2 diabetes (35, 36).”
BackgroundRole of Gut Microbiome in Polycystic Ovary Syndrome
Zaghi, Z., Siadat, S. D., Ejtahed, H., Shirzad, N., Hasani‐Ranjbar, S., & Larijani, B. A. (2021) · DOAJ (DOAJ: Directory of Open Access Journals)
Dehghan, A., Pinto, R. C., Karaman, İ., Huang, J. V., Durainayagam, B. R., Liggi, S., Whiley, L., Mustafa, R., Kivipelto, M., Solomon, A., et al. (2021) · medRxiv · doi:10.1101/2021.04.06.21254991
Self-citationBos, M. M., Goulding, N., Lee, M. A., Hofman, A., Bot, M., Pool, R., Vijfhuizen, L. S., Zhang, X., Li, C., Mustafa, R., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.119
Obesity, Metabolic Syndrome and Inflammation
Lee, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-86684-6_7
Branched-chain amino acids and trimethylamine N-oxide as biomarkers of cardiometabolic outcomes
Flores-Guerrero, J. L. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.192215052
Scalbert, A., & Ferrari, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-812784-1.00010-4
The metabolomic signature of weight loss in the Diabetes Remission Clinical Trial (DiRECT)Preprint
Corbin, L. J., Hughes, D. A., Bull, C. J., Vincent, E. E., Smith, M. L., McConnachie, A., Messow, C., Welsh, P. I., Taylor, R., Lean, M. E. J., et al. (2022) · medRxiv · doi:10.1101/2022.07.15.22277671
Precision Nutrition and Metabolomics, a Model of Alzheimer’s Disease
Ledinger, S., Ludwig-Papst, C., & Scheffler, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-10153-3_7
Mosley, J. D., Shi, M., Agamasu, D., Vaitinadin, N. S., Murthy, V. L., Shah, R. V., Bagheri, M., & Ferguson, J. F. (2023) · medRxiv · doi:10.1101/2023.05.23.23290391
The association between body mass index and metabolite response to a liquid mixed meal challengePreprint
Hughes, D. A., Li‐Gao, R., Bull, C. J., de Mutsert, R., Rosendaal, F. R., Mook-Kanamori, D. O., van Dijk, K. W., & Timpson, N. J. (2023) · medRxiv · doi:10.1101/2023.08.21.23294369
Vanweert, F. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231117fv · Cited by 1
Bos, M. M., Goulding, N., Lee, M. A., Hofman, A., Bot, M., Pool, R., Vijfhuizen, L. S., Zhang, X., Li, C., Mustafa, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14234926
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921757
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921763
Luo, S., Lam, H. S., Chan, Y. H., Tang, C. S.-M., He, B., Kwok, M. K., Leung, G. M., Schooling, C. M., & Yeung, S. L. A. (2023) · Figshare · doi:10.6084/m9.figshare.24465040
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921751
Wang, W., Liu, Z., Liu, L., Han, T., Yang, X., & Sun, C. (2021) · Figshare · doi:10.6084/m9.figshare.16921769
Jiang, L., Yu, Y., Sun, Y., Fu, Y., Shen, W., Cai, L., Tan, X., Cai, Y., Wang, N., Lu, Y., et al. (2024) · medRxiv · doi:10.1101/2024.05.14.24307378
Wang, Y., Gao, Y., & Zhao, B. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100471
RetractedLi, J., Yu, Y., Sun, Y. B., Fu, Y., Shen, W., Cai, L., Tan, X. W., Wang, N., Lu, Y., & Wang, B. (2024) · doi:10.7554/elife.98709.1 · Cited by 1
Li, J., Yu, Y., Sun, Y. B., Fu, Y., Shen, W., Cai, L., Tan, X. W., Cai, Y., Wang, N., Lu, Y., et al. (2024) · doi:10.7554/elife.98709.2
Luo, J. M., le Cessie, S., van Dijk, K. W., Hägg, S., Graßmann, F., van Heemst, D., & Noordam, R. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101991
Deng, Y., Zeng, L., Lai, Y., Ji, S., Peng, B., Lu, H., Wang, M., Kwan, H. Y., Wang, Q., & Zhao, X. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112677
Yesian, A. R., Lam, B., Kim, H. I., Day, F. R., Williamson, A., Jia, R., Lockhart, S. M., Rainbow, K., Kaimakis, V., Antypa, M., et al. (2025) · medRxiv · doi:10.1101/2025.09.30.25336995
“We first genotyped 1,000 participants from the Fenland study 20 for both possible variants and found a minor allele frequency for HCAR2 p.R311C of ~17%.”
Self-citation
Metadata
- Authors
- Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., Marney, L., Koulman, A., Karoly, E. D., Forouhi, N. G., Sjögren, R. J. O., Näslund, E., Zierath, J. R., Krook, A., Savage, D. B., Griffin, J. L., Chaturvedi, N., Hingorani, A. D., Khaw, K.-T., Barroso, I., McCarthy, M. I., O’Rahilly, S., Wareham, N. J., & Langenberg, C.
- Affiliations
- University of Cambridge (GB)
- University College London (GB)
- MRC Elsie Widdowson Laboratory (GB)
- Metabolon (United States) (US)
- Karolinska Institutet (SE)
- Danderyds sjukhus (SE)
- Centre for Human Genetics (GB)
- Corresponding author
- Wareham, Nicholas J.
- Langenberg, Claudia
- ORCID
- Lotta, Luca A.
- Scott, Robert A.
- Sharp, Stephen J.
- Burgess, Stephen
- Luan, Jian’an
- Tillin, Therese
- Schmidt, Amand F.
- Imamura, Fumiaki
- Perry, John R. B.
- Marney, Luke
- Koulman, Albert
- Karoly, Edward D.
- Forouhi, Nita G.
- Sjögren, Rasmus J. O.
- Näslund, Erik
- Zierath, Juleen R.
- Krook, Anna
- Savage, David B.
- Griffin, Julian L.
- Chaturvedi, Nishi
- Hingorani, Aroon D.
- Khaw, Kay-Tee
- Barroso, Inês
- McCarthy, Mark I.
- O’Rahilly, Stephen
- Wareham, Nicholas J.
- Langenberg, Claudia
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-11-29
- Volume
- 13
- Issue
- 11
- Pages
- e1002179
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC5127513
- OpenAlex
- W2559236589
- Cited by
- 417
- References
- 73
- Citations by year
- 2026: 20 · 2025: 38 · 2024: 43 · 2023: 50 · 2022: 49 · 2021: 61 · 2020: 50 · 2019: 31 · 2018: 52 · 2017: 21 · 2016: 1
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Medical Research Council (MC_UU_12015/1, MC_PC_13046, MC_PC_13048 and MR/L00002/1 - MRC Epidemiology Unit, MC_UP_A090_1006 - MRC Human Nutrition Research, SABRE Study)
- National Institute for Health Research (Biomedical Research Centre—MRC Epidemiology Unit)
- EMIF (n° 115372)
- Cambridge Lipidomics Biomarker Research Initiative (G0800783 - MRC Epidemiology Unit and MRC Human Nutrition Research)
- Diabetes UK (SABRE Study)
- British Heart Foundation (GB) (SABRE Study)
- Wellcome Trust (GB) (WT082464 - SABRE Study, SP/07/001/23603 - SABRE Study)
- Diabetes UK (GB) (13/0004774 - SABRE Study)
- Vetenskapsrådet (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Novo Nordisk Foundation (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Diabetes Wellness (Rasmus J O Sjögren, Erik Näslund, Juleen R. Zierath and Anna Krook)
- Wellcome Trust (107064, 090532, 098381, WT098051)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Keywords
- branched-chain amino acids, type 2 diabetes, branched-chain amino acid metabolism, PPM1K, branched-chain ketoacid dehydrogenase, genetic susceptibility, causal inference, isoleucine, leucine, valine, circulating amino acids, polygenic risk score, heritability, pleiotropy, mitochondrial metabolism, metabolite accumulation
- MeSH terms
- Adult, Aged, Amino Acids, Branched-Chain, Diabetes Mellitus, Type 2, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Sweden, Genetic Predisposition to Disease, Genome-Wide Association Study, Young Adult, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.